CA Patent

CA2674915C — Process for preparing oxymorphone

Assigned to Penick Corp · Expires 2015-06-30 · 11y expired

What this patent protects

Methods are provided which include converting oripavine to other opiates, including converting oripavine to 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included.

USPTO Abstract

Methods are provided which include converting oripavine to other opiates, including converting oripavine to 14-hydroxymorphinone and/or converting 14-hydroxymorphinone to oxymorphone. Purification and salt formation are optionally included.

Drugs covered by this patent

oxymorphone-hydrochloride (OXYMORPHONE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2674915C
Jurisdiction: CA
Classification: —
Expires: 2015-06-30
Drug substance claim: No
Drug product claim: No
Assignee: Penick Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.